Warner Bros. Discovery, Inc.
CRYSTAL FORM OF EGFR INHIBITOR AND PREPARATION METHOD THEREOF
Last updated:
Abstract:
Disclosed are a crystal form of an EGFR inhibitor and a preparation method thereof. Further disclosed is an application of the crystal form in preparing a drug for treating non-small cell lung cancer, especially an application in preparing a drug for treating non-small cell lung cancer with brain metastases. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
10 Apr 2020
Issue date:
23 Jun 2022